Qualitative analysis of studies included in the systematic review. Moreover, 49 patients were treated with sham-CPAP, 21 with mandibular advancement devices, and 12 with CPAP and simultaneous TRT; they were not included in the present review. A total of 388 male patients were included, of which 245 received oral and 143 nasal CPAP; information on the presence of diabetes was available for 44 patients (11%) (22, 29). Ten studies were prospective cohort and two randomized controlled. Concerning the two RCTs, data on allocation concealment were not reported; the remaining domains were adequate in both (28, 29). The outcome measures of interest were taken more than once after CPAP in two studies (22, 27). The loss to follow-up was 20% or less in five studies (9, 23, 24, 26).
If hematocrit climbs, your clinician may lower the dose, split injections, switch formulations, or pause therapy. Expect sexual benefits within weeks, energy and mood within 1–2 months, and body composition changes over 3–6 months alongside resistance training and protein intake. If you’re trying to conceive, avoid standard testosterone, it suppresses sperm production. Pellet implants provide months of treatment after a brief procedure, convenient but less adjustable.
Sleep position is among the most impactful — sleeping on your back allows gravity to pull the tongue and soft tissues backward, narrowing the airway. Beyond devices and medical interventions, several lifestyle modifications can meaningfully reduce snoring testosterone. The Snorple mouthpiece was specifically engineered around this combined approach, based on clinical evidence that dual-mechanism treatment produces significantly better airway opening than either approach alone. Mandibular advancement devices (MADs) work by repositioning the lower jaw slightly forward during sleep, which increases the space behind the tongue and reduces the likelihood of airway collapse. By the time symptoms become impossible to ignore, the underlying damage may be significant. What makes low testosterone sleep particularly dangerous is how gradually the damage accumulates. These are not hypothetical risks — they are documented outcomes of prolonged oxygen deprivation during sleep.
The importance of regular follow-ups with healthcare providers cannot be overstated. These may include weight loss, regular exercise, stress reduction techniques, and improving sleep hygiene. For low testosterone, Testosterone Replacement Therapy (TRT) is often prescribed. While CPAP can be highly effective, some patients may find it uncomfortable or difficult to adjust to. Recognizing the common symptoms of each condition is the first step in seeking appropriate medical attention. This cycle can be particularly challenging to break without addressing both the hormonal imbalance and the sleep disorder. Hypoxia can lead to oxidative stress and inflammation, which may directly impact the function of the testes and the hypothalamic-pituitary-gonadal axis responsible for testosterone production.
This should be kept in mind in patients with OSA and hypogonadism who are considering TRT. If the patient is unresponsive or cannot tolerate CPAP, the testosterone dose must be reduced or discontinued. Other plausible explanations include a role for testosterone in the neural response pathways to hypoxia and hypercapnia . Unlike the effects of CPAP, there is a linear relationship between weight loss and increased plasma testosterone in obese men . Although obesity leads to a lower testosterone level, low testosterone may also promote obesity . This may be because adipose tissue, especially when inflamed and in an insulin-resistant state, expresses aromatase, which converts testosterone to 17β-estradiol . Furthermore, the frequency of awakening and REM latency also increase during sleep with aging 12,13.
These results were drawn from the analysis of seven studies, all included in the present paper (9, 22, 23, 27–29, 31). The authors stated that CPAP does not influence serum total testosterone, free testosterone, and SHBG. A significant increase in serum total testosterone was reported only in the third group (28–30). Since CPAP has shown a neutral effect on serum total testosterone, no different result should be expected for the other outcomes, indeed (43). Since ~70% of serum testosterone is bound to SHBG, current guidelines recommend determining the androgen status through the evaluation of serum free testosterone, either directly from equilibrium dialysis assays or by calculations that use serum total testosterone, SHBG, and albumin (11).
Testosterone levels normally rise during REM sleep, but men with Low T may not reach or stay in this stage as often. It is the time when most dreaming occurs, but more importantly, it is linked to brain health, mood, and learning. Over time, the lack of deep sleep leaves men feeling unrefreshed and exhausted in the morning. These awakenings may be short, but they prevent the body from reaching deep, restorative sleep. Men with Low T often report waking up many times during the night. Hot flashes can wake a man up several times during the night, making it difficult to get a full night’s rest. Instead, they happen because testosterone helps the brain regulate body temperature.
This creates a cycle where sleep problems make Low T worse, and Low T makes sleep problems worse. Weight management, exercise, and good sleep habits are also key parts of care. Extra weight, a thicker neck, and certain lifestyle habits increase the risk. Sleep apnea is a condition where breathing stops or becomes very shallow during sleep.
Papers were searched without time restrictions, inclusion criteria were defined prior to the database search, and data were searched on original articles and supplementary data. To our knowledge, this is the first systematic review and meta-analysis assessing differences due to CPAP use in eugonadal and hypogonadal patients with OSA syndrome, as well as focusing on gonadotropins. The overall results of our meta-analysis showed that CPAP does not influence total testosterone or gonadotropins. Data were available for 95 patients with hypogonadism and 280 with eugonadism at baseline.

Gender: Female

Social links